Candida albicans overgrowth disrupts the gut microbiota in mice bearing oral cancer

References

• Akuzum B, Lee JY. 2022. Context-dependent regulation of type 17 immunity by microbiota at the intestinal barrier. Immune Netw. 22(6):e46. doi: 10.4110/in.2022.22.e46.
   PubMed Web of Science ®Google Scholar
• Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. 2016. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog. 8(1):42. doi: 10.1186/s13099-016-0124-2.
   PubMed Web of Science ®Google Scholar
• An J, Kwon H, Kim YJ. 2023. The Firmicutes/Bacteroidetes ratio as a risk factor of breast cancer. J Clin Med. 12(6):2216. doi: 10.3390/jcm12062216.
   PubMed Web of Science ®Google Scholar
• Bertolini M, Ranjan A, Thompson A, Diaz PI, Sobue T, Maas K, Dongari-Bagtzoglou A. 2019. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection. PLoS Pathog. 15(4):e1007717. doi: 10.1371/journal.ppat.1007717.
   PubMed Web of Science ®Google Scholar
• Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S, Mazieres J, Audigier-Valette C, Moro-Sibilot D, Goldwasser F, et al. 2022. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 28(2):315–324. doi: 10.1038/s41591-021-01655-5.
   PubMed Web of Science ®Google Scholar
• Derrien M, Belzer C, de Vos WM. 2017. Akkermansia muciniphila and its role in regulating host functions. Microb Pathog. 106:171–181. doi:10.1016/j.micpath.2016.02.005.
   PubMed Web of Science ®Google Scholar
• Douzandeh-Mobarrez B, Kariminik A. 2019. Gut microbiota and IL-17A: Physiological and pathological responses. Probiotics Antimicrob Proteins. 11(1):1–10. doi: 10.1007/s12602-017-9329-z.
   PubMed Web of Science ®Google Scholar
• Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 27(16):2194–2200. doi: 10.1093/bioinformatics/btr381.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. 2018. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 33(4):570–580. doi: 10.1016/j.ccell.2018.03.015.
   PubMed Web of Science ®Google Scholar
• Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. 2019. The microbiome, cancer, and cancer therapy. Nat Med. 25(3):377–388. doi: 10.1038/s41591-019-0377-7.
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207–214. doi: 10.1038/nature11234.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Tuganbaev T, AN S, Honda K. 2022. T cell responses to the microbiota. Annu Rev Immunol. 40(1):559–587. doi: 10.1146/annurev-immunol-101320-011829.
   PubMedGoogle Scholar
• Kumari A, Tripathi AH, Gautam P, Gahtori R, Pande A, Singh Y, Madan T, Upadhyay SK. 2021. Adhesins in the virulence of opportunistic fungal pathogens of human. Mycology. 12(4):296–324. doi: 10.1080/21501203.2021.1934176.
   PubMed Web of Science ®Google Scholar
• Leibovitzh H, Lee SH, Xue M, Raygoza Garay JA, Hernandez-Rocha C, Madsen KL, Meddings JB, Guttman DS, Espin-Garcia O, Smith MI, et al. 2022. Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn’s disease. Gastroenterology. 163(5):1364–1376. doi:10.1053/j.gastro.2022.07.004.
   PubMed Web of Science ®Google Scholar
• Longa CMO, Nicola L, Antonielli L, Mescalchin E, Zanzotti R, Turco E, Pertot I. 2017. Soil microbiota respond to green manure in organic vineyards. J Appl Microbiol. 123(6):1547–1560. doi: 10.1111/jam.13606.
   PubMed Web of Science ®Google Scholar
• Ma L, Ni Y, Wang Z, Tu W, Ni L, Zhuge F, Zheng A, Hu L, Zhao Y, Zheng L, et al. 2020. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes. 12(1):1–19. doi: 10.1080/19490976.2020.1832857.
   PubMed Web of Science ®Google Scholar
• Magoc T, Salzberg SL. 2021. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 27(21):2957–2963. doi: 10.1093/bioinformatics/btr507.
   Google Scholar
• Majumder S, Mcgeachy MJ. 2021. IL-17 in the pathogenesis of disease: good intentions gone awry. Annu Rev Immunol. 39:537–556. doi:10.1146/annurev-immunol-101819-092536.
   PubMed Web of Science ®Google Scholar
• Mcgeachy MJ, Cua DJ, Gaffen SL. 2019. The IL-17 family of cytokines in health and disease. Immunity. 50(4):892–906. doi: 10.1016/j.immuni.2019.03.021.
   PubMed Web of Science ®Google Scholar
• Mengesha BG, Conti HR. 2017. The role of IL-17 in protection against mucosal Candida infections. J Fungi (Basel). 3(4):52. doi: 10.3390/jof3040052.
   PubMedGoogle Scholar
• Mohamed N, Litlekalsøy J, Ahmed IA, Martinsen EMH, Furriol J, Javier-Lopez R, Elsheikh M, Gaafar NM, Morgado L, Mundra S, et al. 2021. Analysis of salivary mycobiome in a cohort of oral squamous cell carcinoma patients from Sudan identifies higher salivary carriage of Malassezia as an independent and favorable predictor of overall survival. Front Cell Infect Microbiol. 11:673465. doi: 10.3389/fcimb.2021.673465.
   PubMed Web of Science ®Google Scholar
• Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, Stewart CJ, Metcalf GA, Muzny DM, Gibbs RA, et al. 2017. The gut mycobiome of the human microbiome project healthy cohort. Microbiome. 5(1):153. doi: 10.1186/s40168-017-0373-4.
   PubMedGoogle Scholar
• Panghal M, Kaushal V, Kadayan S, Yadav JP. 2012. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health. 12:22. doi:10.1186/1472-6831-12-22.
   PubMed Web of Science ®Google Scholar
• Papotto PH, Yilmaz B, Silva-Santos B. 2021. Crosstalk between gammadelta T cells and the microbiota. Nat Microbiol. 6(9):1110–1117. doi: 10.1038/s41564-021-00948-2.
   PubMed Web of Science ®Google Scholar
• Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. 2020. The genus Alistipes: Gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 11:906. doi:10.3389/fimmu.2020.00906.
   PubMed Web of Science ®Google Scholar
• Reis BS, Darcy PW, Khan IZ, Moon CS, Kornberg AE, Schneider VS, Alvarez Y, Eleso O, Zhu C, Schernthanner M, et al. 2022. TCR-Vgammadelta usage distinguishes protumor from antitumor intestinal gammadelta T cell subsets. Sci. 377(6603):276–284. doi:10.1126/science.abj8695.
   PubMed Web of Science ®Google Scholar
• Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. 2018a. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 15(6):382–396. doi: 10.1038/s41571-018-0006-2.
   PubMed Web of Science ®Google Scholar
• Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. 2018b. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Sci. 359(6371):91–97. doi:10.1126/science.aan3706.
   PubMed Web of Science ®Google Scholar
• Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. 2021. The microbiome and human cancer. Sci. 371(6536):eabc4552. doi: 10.1126/science.abc4552.
   PubMed Web of Science ®Google Scholar
• Shiao SL, Kershaw KM, Limon JJ, You S, Yoon J, Ko EY, Guarnerio J, Potdar AA, McGovern DPB, Bose S, et al. 2021. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell. 39(9):1202–1213. doi:10.1016/j.ccell.2021.07.002.
   PubMed Web of Science ®Google Scholar
• Shiromizu CM, Jancic CC. 2018. Gammadelta T lymphocytes: An effector cell in autoimmunity and infection. Front Immunol. 9:2389. doi:10.3389/fimmu.2018.02389.
   PubMed Web of Science ®Google Scholar
• Stojanov S, Berlec A, Strukelj B. 2020. The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms. 8(11):1715. doi: 10.3390/microorganisms8111715.
   PubMed Web of Science ®Google Scholar
• Takiishi T, Fenero C, Camara N. 2017. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers. 5(4):e1373208. doi: 10.1080/21688370.2017.1373208.
   PubMed Web of Science ®Google Scholar
• Ting NL, Lau HC, Yu J. 2022. Cancer pharmacomicrobiomics: Targeting microbiota to optimise cancer therapy outcomes. Gut. 71(7):1412–1425. doi: 10.1136/gutjnl-2021-326264.
   PubMed Web of Science ®Google Scholar
• Umazume M, Ueta E, Osaki T. 1995. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol. 33(2):432–439. doi: 10.1128/jcm.33.2.432-439.1995.
   PubMed Web of Science ®Google Scholar
• Vaiserman A, Romanenko M, Piven L, Moseiko V, Lushchak O, Kryzhanovska N, Guryanov V, Koliada A. 2020. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 20(1):221. doi: 10.1186/s12866-020-01903-7.
   PubMed Web of Science ®Google Scholar
• van Thiel IAM, Rahman S, Hakvoort TBM, Davids M, Verseijden C, van Hamersveld PHP, Bénard MV, Lodders MH, Boekhout T, van den Wijngaard RM, et al. 2022. Fecal Filobasidium is associated with clinical remission and endoscopic response following fecal microbiota transplantation in mild-to-moderate ulcerative colitis. Microorganisms. 10(4):737. doi: 10.3390/microorganisms10040737.
   PubMed Web of Science ®Google Scholar
• Wang F, Ye Y, Xin C, Liu F, Zhao C, Xiang L, Song Z. 2021. Candida albicans triggers qualitative and temporal responses in gut bacteria. J Mycol Med. 31(3):101164. doi: 10.1016/j.mycmed.2021.101164.
   PubMed Web of Science ®Google Scholar
• Wang X, Wu S, Wu W, Zhang W, Li L, Liu Q, Yan Z. 2023a. Candida albicans promotes oral cancer via IL-17A/IL-17RA-macrophage axis. mBio. 14(3):e0044723. doi: 10.1128/mbio.00447-23.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang W, Wu W, Wu S, Young A, Yan Z. 2023b. Is Candida albicans a contributor to cancer? A critical review based on the current evidence. Microbiol Res. 272:127370. doi:10.1016/j.micres.2023.127370.
   PubMedGoogle Scholar
• Wei W, Li J, Shen X, Lyu J, Yan C, Tang B, Ma W, Xie H, Zhao L, Cheng L, et al. 2022. Oral microbiota from periodontitis promote oral squamous cell carcinoma development via gammadelta T cell activation. mSystems. 7(5):e46922. doi:10.1128/msystems.00469-22.
   Web of Science ®Google Scholar
• Zaongo SD, Ouyang J, Isnard S, Zhou X, Harypursat V, Cui H, Routy JP, Chen Y. 2023. Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection. Gut Microbes. 15(1):2167171. doi: 10.1080/19490976.2023.2167171.
   PubMed Web of Science ®Google Scholar
• Zhou QH, Wu FT, Pang LT, Zhang TB, Chen Z. 2020. Role of gammadelta T cells in liver diseases and its relationship with intestinal microbiota. World J Gastroenterol. 26(20):2559–2569. doi: 10.3748/wjg.v26.i20.2559.
   PubMed Web of Science ®Google Scholar